ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.460
-0.090 (-5.81%)
At close: Feb 5, 2026, 4:00 PM EST
1.450
-0.010 (-0.68%)
After-hours: Feb 5, 2026, 4:21 PM EST
ProQR Therapeutics Market Cap
ProQR Therapeutics has a market cap or net worth of $153.8 million as of February 5, 2026. Its market cap has decreased by -18.15% in one year.
Market Cap
153.80M
Enterprise Value
50.88M
1-Year Change
-18.15%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since September 18, 2014, ProQR Therapeutics's market cap has decreased from $308.80M to $153.80M, a decrease of -50.19%. That is a compound annual growth rate of -5.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 167.00M | -23.25% |
| Dec 31, 2025 | 217.60M | -2.55% |
| Dec 31, 2024 | 223.30M | 33.87% |
| Dec 29, 2023 | 166.80M | -39.78% |
| Dec 30, 2022 | 277.00M | -53.81% |
| Dec 31, 2021 | 599.70M | 164.07% |
| Dec 31, 2020 | 227.10M | -46.89% |
| Dec 31, 2019 | 427.60M | -15.11% |
| Dec 31, 2018 | 503.70M | 568.92% |
| Dec 29, 2017 | 75.30M | -34.18% |
| Dec 30, 2016 | 114.40M | -43.53% |
| Dec 31, 2015 | 202.60M | -55.40% |
| Dec 31, 2014 | 454.30M | 47.12% |
| Sep 18, 2014 | 308.80M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 171.43M |
| Kalaris Therapeutics | 170.38M |
| Molecular Partners AG | 170.21M |
| Compugen | 169.30M |
| Prelude Therapeutics | 167.27M |
| Zentalis Pharmaceuticals | 162.52M |
| Century Therapeutics | 160.83M |
| Opus Genetics | 160.00M |